The Challenges in Manufacturing Biologics [Video]

This content is brought to you by Amgen This video summarizes the complex process of creating biologics from start to finish and describes some of the unique challenges-- and tremendous effort-- involved in delivering safe and effective biologics.

Related Videos

Related Content

Advertisement

March 11th 2025

Americans Give US Health Care System a C Grade, Calling for Policy Change

Hayden E. Klein

A new report shows most Americans believe the government is too involved in health care regulation and want to see a ban on pharmaceutical company advertisements in the US.

February 18th 2025

Varied Access: The Pharmacogenetic Testing Coverage Divide

Brooke McCormick Jai N. Patel, PharmD

On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.

March 7th 2025

Shaping Dermatology's Future by Increasing Access, Data, and Advocacy

Brooke McCormick

Thy N. Huynh, MD, FAAD, Bruce A. Brod, MHCI, MD, FAAD, and Melissa Piliang, MD, FAAD, discussed expanding access to pediatric dermatology, dermatology data aggregation, and advocacy for Medicare physician payment reform, respectively.

February 11th 2025

Telemedicine’s Evolution and Expanding Access to Obesity, Specialty Care

Maggie L. Shaw George Jones

George Jones of UpScript Health discusses telemedicine's evolution from basic e-prescribing to real-time video consultations, expanding treatment beyond primary care.

March 5th 2025

Senate Questions NIH Nominee on Funding, Transparency, and COVID-19 Impact

Pearl Steinzor

Jay Bhattacharya, MD, PhD, defended his vision for the National Institutes of Health in a Senate committee confirmation hearing, tackling concerns on research funding, public trust, and scientific integrity.

March 5th 2025

Contributor: How Can the US Health Care System Affordably and Fairly Expand GLP-1 Access for the Millions of People Who Need it?

Wei-Li Shao, MBA

Expanding coverage and access to glucagon-like peptide-1 (GLP-1) medication can be beneficial for all with the cooperation of multiple parties in health care.

Related Content

Advertisement

March 11th 2025

Americans Give US Health Care System a C Grade, Calling for Policy Change

Hayden E. Klein

A new report shows most Americans believe the government is too involved in health care regulation and want to see a ban on pharmaceutical company advertisements in the US.

February 18th 2025

Varied Access: The Pharmacogenetic Testing Coverage Divide

Brooke McCormick Jai N. Patel, PharmD

On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.

March 7th 2025

Shaping Dermatology's Future by Increasing Access, Data, and Advocacy

Brooke McCormick

Thy N. Huynh, MD, FAAD, Bruce A. Brod, MHCI, MD, FAAD, and Melissa Piliang, MD, FAAD, discussed expanding access to pediatric dermatology, dermatology data aggregation, and advocacy for Medicare physician payment reform, respectively.

February 11th 2025

Telemedicine’s Evolution and Expanding Access to Obesity, Specialty Care

Maggie L. Shaw George Jones

George Jones of UpScript Health discusses telemedicine's evolution from basic e-prescribing to real-time video consultations, expanding treatment beyond primary care.

March 5th 2025

Senate Questions NIH Nominee on Funding, Transparency, and COVID-19 Impact

Pearl Steinzor

Jay Bhattacharya, MD, PhD, defended his vision for the National Institutes of Health in a Senate committee confirmation hearing, tackling concerns on research funding, public trust, and scientific integrity.

March 5th 2025

Contributor: How Can the US Health Care System Affordably and Fairly Expand GLP-1 Access for the Millions of People Who Need it?

Wei-Li Shao, MBA

Expanding coverage and access to glucagon-like peptide-1 (GLP-1) medication can be beneficial for all with the cooperation of multiple parties in health care.